Upgrade to SI Premium - Free Trial

Pfizer (PFE) Announces FDA Approves for its Neupogen Biosimilar NIVESTYM

July 20, 2018 4:26 PM
Pfizer Inc. (NYSE: PFE) today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved NIVESTYM™ (filgrastim-aafi) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments

Next Articles